Too often, it's government bureaucrats acting under the influence of special interests and against the wishes of doctors and patients, with sometimes tragic results.
Cuban's Cost Plus Drugs project brings a bit of free market flair to the health care industry, but the lack of meaningful price signals is only part of the problem.